(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Thursday that the capital reduction required for the demerger of StemPrintER Sciences, and to enable the ultimate allotment of Accustem Sciences shares to its shareholders, has been sanctioned by the court.
The AIM-traded firm said the sanction date was 27 October, as it had anticipated.

"The company expects to file the court order with Companies House later today, also as anticipated, at which point the capital reduction will become effective," Tiziana said in its short statement.

At 1602 GMT, shares in Tiziana Life Sciences were up 2.39% at 158.7p.